SynthesisMedicine2018

Gefitinib provides similar effectiveness and improved safety than erlotinib for advanced non-small cell lung cancer: A meta-analysis.

Wenxiong Zhang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.